Drug Profile
Risperidone - Yung Shin Pharmaceutical
Alternative Names: RCN-3028Latest Information Update: 12 Dec 2023
Price :
$50
*
At a glance
- Originator Yung Shin Pharmaceutical
- Class Antidepressants; Antineoplastics; Antipsychotics; Behavioural disorder therapies; Fluorinated hydrocarbons; Isoxazoles; Mood stabilisers; Piperidines; Pyrimidinones; Small molecules
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Hot flashes; Vasomotor symptoms
Most Recent Events
- 28 Sep 2017 Yung Shin Pharm completes phase II trials for Hot flashes and Vasomotor symptoms in Taiwan (NCT02100540)
- 14 Jul 2016 Risperidone is still in phase II trials for Hot flashes and Vasomotor symptoms in Taiwan (NCT02100540)
- 31 Mar 2014 Phase-II clinical trials in Hot flashes and Vasomotor symptoms in Taiwan (PO)